Live Breaking News & Updates on Gables Capital Management

Stay updated with breaking news from Gables capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vinva Investment Management Ltd Grows Stake in Trane Technologies plc (NYSE:TT)

Vinva Investment Management Ltd boosted its position in shares of Trane Technologies plc (NYSE:TT – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 6,971 shares of the company’s stock after purchasing an additional 365 shares during the quarter. Vinva Investment Management Ltd’s holdings in Trane Technologies were worth $1,700,000 […] ....

Christopherj Kuehn , Evanm Turtz , Vinva Investment Management Ltd , Ancora Advisors , Wealth Management , Wells Fargo Company , Holdings Channel , Gables Capital Management Inc , Securities Exchange Commission , Trane Technologies Company Profile , Trane Technologies , Free Report , Investment Management Ltd , Gables Capital Management , Capital Management , Exchange Commission , Get Free Report , Visit Holdingschannel , Trane Technologies Daily ,

930 Shares in Trane Technologies plc (NYSE:TT) Bought by Allstate Corp

930 Shares in Trane Technologies plc (NYSE:TT) Bought by Allstate Corp
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Christopherj Kuehn , Davids Regnery , Robertw Baird , Goldman Sachs Group , Royal Bank , Securities Exchange Commission , Wealth Management , Allstate Corp , Gables Capital Management Inc , Ancora Advisors , Trane Technologies , Free Report , Gables Capital Management , Capital Management , Exchange Commission , Get Free Report , Visit Holdingschannel , Trane Technologies Daily ,

CreativeOne Wealth LLC Lowers Position in Vanguard Financials ETF (NYSEARCA:VFH)

CreativeOne Wealth LLC reduced its position in Vanguard Financials ETF (NYSEARCA:VFH – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,185 shares of the company’s stock after selling 575 shares during the period. CreativeOne Wealth […] ....

United States , Exchange Commission , Creativeone Wealth , Vanguard Financials Index Fund , Atlantic Edge Private Wealth Management , Exchange Capital Management Inc , Foundations Investment Advisors , Corient Private Wealth , Gables Capital Management Inc , Vanguard Financials , Free Report , One Wealth , Private Wealth , Edge Private Wealth Management , Capital Management , Investment Advisors , Gables Capital Management , Vanguard Financials Index , Morgan Stanley Capital International , Market Financials Index , Global Industry Classification Standard ,

FineMark National Bank & Trust Has $13.30 Million Stake in Trane Technologies plc (NYSE:TT)

FineMark National Bank & Trust raised its position in Trane Technologies plc (NYSE:TT – Free Report) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 54,528 shares of the company’s stock after purchasing an additional 399 shares during the quarter. FineMark National […] ....

Davids Regnery , Evanm Turtz , Royal Bank , Wells Fargo Company , Finemark National Bank , Wealth Management , Exchange Commission , Securities Exchange Commission , Gables Capital Management Inc , Ancora Advisors , Trane Technologies , Free Report , Mark National Bank , Gables Capital Management , Capital Management , Get Free Report , Visit Holdingschannel , Trane Technologies Daily ,

HC Wainwright Reaffirms Buy Rating for Outlook Therapeutics (NASDAQ:OTLK)

HC Wainwright reissued their buy rating on shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) in a report published on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. HC Wainwright also issued estimates for Outlook Therapeutics’ Q1 2025 earnings at ($1.00) EPS, Q2 2025 earnings at ($0.50) EPS, Q3 […] ....

Rosalind Advisors Inc , Gables Capital Management Inc , Outlook Therapeutics Inc , Scotia Capital Inc , Outlook Therapeutics , Free Report , One Financial , Capital Management , Chardan Capital , Moderate Buy , Gables Capital Management , Get Free Report , Outlook Therapeutics Daily ,